Simvastatin Inhibits the Malignant Behaviors of Gastric Cancer Cells by Simultaneously Suppressing YAP and β-Catenin Signaling

BACKGROUND: Statins, which are used to lower blood cholesterol levels by inhibiting HMG-CoA reductase, have shown anticancer effects in many cancer cells. However, the role of statins in gastric cancer remains unclear. This study aims to investigate whether the statins could antagonize progression o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Onco Targets Ther
Main Authors: Liu, Qing, Xia, Hongwei, Zhou, Sheng, Tang, Qiulin, Zhou, Jitao, Ren, Min, Bi, Feng
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7074824/
https://ncbi.nlm.nih.gov/pubmed/32210573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S237693
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki